Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Ulcerative Colitis Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Ulcerative Colitis Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Oral
      • 1.3.3 Injection
    • 1.4 Market Segment by Application
      • 1.4.1 Global Ulcerative Colitis Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drugs Stores
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Ulcerative Colitis Production Value 2014-2025
      • 2.1.2 Global Ulcerative Colitis Production 2014-2025
      • 2.1.3 Global Ulcerative Colitis Capacity 2014-2025
      • 2.1.4 Global Ulcerative Colitis Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Ulcerative Colitis Market Size CAGR of Key Regions
      • 2.2.2 Global Ulcerative Colitis Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Ulcerative Colitis Capacity by Manufacturers
      • 3.1.2 Global Ulcerative Colitis Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Ulcerative Colitis Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ulcerative Colitis Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
    • 3.3 Ulcerative Colitis Price by Manufacturers
    • 3.4 Key Manufacturers Ulcerative Colitis Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Ulcerative Colitis Market
    • 3.6 Key Manufacturers Ulcerative Colitis Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Oral Production and Production Value (2014-2019)
      • 4.1.2 Injection Production and Production Value (2014-2019)
    • 4.2 Global Ulcerative Colitis Production Market Share by Type
    • 4.3 Global Ulcerative Colitis Production Value Market Share by Type
    • 4.4 Ulcerative Colitis Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Ulcerative Colitis Consumption by Application

    6 Production by Regions

    • 6.1 Global Ulcerative Colitis Production (History Data) by Regions 2014-2019
    • 6.2 Global Ulcerative Colitis Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Ulcerative Colitis Production Growth Rate 2014-2019
      • 6.3.2 United States Ulcerative Colitis Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Ulcerative Colitis Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Ulcerative Colitis Production Growth Rate 2014-2019
      • 6.4.2 European Union Ulcerative Colitis Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Ulcerative Colitis Import & Export
    • 6.5 China
      • 6.5.1 China Ulcerative Colitis Production Growth Rate 2014-2019
      • 6.5.2 China Ulcerative Colitis Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Ulcerative Colitis Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Ulcerative Colitis Consumption by Regions

    • 7.1 Global Ulcerative Colitis Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Ulcerative Colitis Consumption by Type
      • 7.2.2 United States Ulcerative Colitis Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Ulcerative Colitis Consumption by Type
      • 7.3.2 European Union Ulcerative Colitis Consumption by Application
    • 7.4 China
      • 7.4.1 China Ulcerative Colitis Consumption by Type
      • 7.4.2 China Ulcerative Colitis Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Ulcerative Colitis Consumption by Type
      • 7.5.2 Rest of World Ulcerative Colitis Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Johnson & Johnson.
      • 8.1.1 Johnson & Johnson. Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Ulcerative Colitis
      • 8.1.4 Ulcerative Colitis Product Introduction
      • 8.1.5 Johnson & Johnson. Recent Development
    • 8.2 AbbVie
      • 8.2.1 AbbVie Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Ulcerative Colitis
      • 8.2.4 Ulcerative Colitis Product Introduction
      • 8.2.5 AbbVie Recent Development
    • 8.3 Takeda Pharmaceuticals
      • 8.3.1 Takeda Pharmaceuticals Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Ulcerative Colitis
      • 8.3.4 Ulcerative Colitis Product Introduction
      • 8.3.5 Takeda Pharmaceuticals Recent Development
    • 8.4 Roche
      • 8.4.1 Roche Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Ulcerative Colitis
      • 8.4.4 Ulcerative Colitis Product Introduction
      • 8.4.5 Roche Recent Development
    • 8.5 Warner Chilcott
      • 8.5.1 Warner Chilcott Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Ulcerative Colitis
      • 8.5.4 Ulcerative Colitis Product Introduction
      • 8.5.5 Warner Chilcott Recent Development
    • 8.6 Salix Pharmaceuticals/Santarus
      • 8.6.1 Salix Pharmaceuticals/Santarus Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Ulcerative Colitis
      • 8.6.4 Ulcerative Colitis Product Introduction
      • 8.6.5 Salix Pharmaceuticals/Santarus Recent Development
    • 8.7 Shire Pharmaceuticals
      • 8.7.1 Shire Pharmaceuticals Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Ulcerative Colitis
      • 8.7.4 Ulcerative Colitis Product Introduction
      • 8.7.5 Shire Pharmaceuticals Recent Development
    • 8.8 Ferring Pharmaceuticals
      • 8.8.1 Ferring Pharmaceuticals Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Ulcerative Colitis
      • 8.8.4 Ulcerative Colitis Product Introduction
      • 8.8.5 Ferring Pharmaceuticals Recent Development
    • 8.9 Pfizer
      • 8.9.1 Pfizer Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Ulcerative Colitis
      • 8.9.4 Ulcerative Colitis Product Introduction
      • 8.9.5 Pfizer Recent Development
    • 8.10 InDeX Pharmaceuticals
      • 8.10.1 InDeX Pharmaceuticals Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Ulcerative Colitis
      • 8.10.4 Ulcerative Colitis Product Introduction
      • 8.10.5 InDeX Pharmaceuticals Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Ulcerative Colitis Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Ulcerative Colitis Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Ulcerative Colitis Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Ulcerative Colitis Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Ulcerative Colitis Production Forecast by Type
      • 9.7.2 Global Ulcerative Colitis Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Ulcerative Colitis Sales Channels
      • 10.2.2 Ulcerative Colitis Distributors
    • 10.3 Ulcerative Colitis Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Anti-inflammatory drugs are often the first step in the treatment of ulcerative colitis. They include: 5-aminosalicylates. Examples of this type of medication includesulfasalazine (Azulfidine), mesalamine (Asacol HD, Delzicol, others), balsalazide (Colazal) and olsalazine (Dipentum).
      In 2019, the market size of Ulcerative Colitis is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ulcerative Colitis.

      This report studies the global market size of Ulcerative Colitis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Ulcerative Colitis production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Johnson & Johnson.
      AbbVie
      Takeda Pharmaceuticals
      Roche
      Warner Chilcott
      Salix Pharmaceuticals/Santarus
      Shire Pharmaceuticals
      Ferring Pharmaceuticals
      Pfizer
      InDeX Pharmaceuticals

      Market Segment by Product Type
      Oral
      Injection

      Market Segment by Application
      Hospital
      Drugs Stores

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Ulcerative Colitis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Ulcerative Colitis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Ulcerative Colitis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now